Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
ANTARES PHARMA, INC. (0001016169)
Standardized SEC financial data for ANTARES PHARMA, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001016169 · Surgical & Medical Instruments & Apparatus.
Gross margin
39.9%
Operating margin
35.8%
Net margin
25.2%
Revenue growth (YoY)
23.0%
Return on equity
26.3%
ROIC
37.3%
Free cash flow
$30.0M
Debt / equity
0.12×
Ratios for fiscal year 2021, standardized from SEC filings.